Literature DB >> 7475661

Detection of diverse HIV-1 genetic subtypes in the USA.

S K Brodine1, J R Mascola, P J Weiss, S I Ito, K R Porter, A W Artenstein, F C Garland, F E McCutchan, D S Burke.   

Abstract

Of the nine genetic subtypes of HIV-1 that exist world wide, subtype B predominates in North America and Europe. Thus, most knowledge about HIV-1 and most vaccine development efforts are based on subtype B viruses. We document here the detection of HIV-1 subtypes A, D, and E in five US servicemen who acquired these non-subtype-B infections during overseas deployments. The dispersal of diverse HIV-1 subtypes into regions of the world with previously restricted genetic diversity may have important implications for the epidemiology of the epidemic and for the design and implementation of vaccine trials.

Entities:  

Mesh:

Year:  1995        PMID: 7475661     DOI: 10.1016/s0140-6736(95)92901-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

1.  Evaluation of the Abbott LCx quantitative assay for measurement of human immunodeficiency virus RNA in plasma.

Authors:  Carmen de Mendoza; José Alcamí; María Sainz; Dolores Folgueira; Vincent Soriano
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Comparison of LCx with other current viral load assays for detecting and quantifying human immunodeficiency virus type 1 RNA in patients infected with the circulating recombinant form A/G (CRF02).

Authors:  Alessandra Amendola; Licia Bordi; Claudio Angeletti; Enrico Girardi; Giuseppe Ippolito; Maria R Capobianchi
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  Integrating laboratory and epidemiological techniques for population-based surveillance of HIV strains and drug resistance in Canada.

Authors:  G C Jayaraman; C P Archibald; L Lior; D Sutherland
Journal:  Can J Infect Dis       Date:  2000-03

4.  The Honduran human immunodeficiency virus type 1 (HIV-1) epidemic is dominated by HIV-1 subtype B as determined by V3 domain sero- and genotyping.

Authors:  C Lara; M Sällberg; B Johansson; I L de Rivera; A Sönnerborg
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 5.  Recurrent CDC group IVc-2 bacteremia in a human with AIDS.

Authors:  R R Anderson; P Warnick; P C Schreckenberger
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 6.  Progress and challenges toward an AIDS vaccine: Brother, can you spare a paradigm?

Authors:  W C Koff; A M Schultz
Journal:  J Clin Immunol       Date:  1996-05       Impact factor: 8.317

7.  Genetic variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil.

Authors:  A Tanuri; A C Vicente; K Otsuki; C A Ramos; O C Ferreira; M Schechter; L M Janini; D Pieniazek; M A Rayfield
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

8.  Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes.

Authors:  Arthur H Robbins; Roxana M Coman; Edith Bracho-Sanchez; Marty A Fernandez; C Taylor Gilliland; Mi Li; Mavis Agbandje-McKenna; Alexander Wlodawer; Ben M Dunn; Robert McKenna
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-02-12

9.  HIV-1 group O virus identified for the first time in the United States.

Authors:  M A Rayfield; P Sullivan; C I Bandea; L Britvan; R A Otten; C P Pau; D Pieniazek; S Subbarao; P Simon; C A Schable; A C Wright; J Ward; G Schochetman
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

10.  Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa.

Authors:  F E McCutchan; A W Artenstein; E Sanders-Buell; M O Salminen; J K Carr; J R Mascola; X F Yu; K E Nelson; C Khamboonruang; D Schmitt; M P Kieny; J G McNeil; D S Burke
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.